Rebiotix Inc. clinical trials
Acquired by Ferring Pharmaceuticals
The registry lists 5 studies whose lead sponsor is Rebiotix Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 7, 2024.
Registry sponsor names on this page
- Rebiotix Inc.5 studies
Something wrong with this grouping? Tell us on the Ferring Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Ferring Pharmaceuticals studies →
- Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)CompletedNCT03931941Phase 3
Sponsor listed in the registry: Rebiotix Inc. · Rebiotix Inc. — acquired company within the Ferring Pharmaceuticals group
- Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)CompletedNCT03244644Phase 3
Sponsor listed in the registry: Rebiotix Inc. · Rebiotix Inc. — acquired company within the Ferring Pharmaceuticals group
- Microbiota Restoration Therapy for Recurrent Clostridium Difficile InfectionCompletedNCT02589847Phase 2
Sponsor listed in the registry: Rebiotix Inc. · Rebiotix Inc. — acquired company within the Ferring Pharmaceuticals group
- Microbiota Restoration Therapy for Recurrent Clostridium Difficile InfectionCompletedNCT02299570Phase 2
Sponsor listed in the registry: Rebiotix Inc. · Rebiotix Inc. — acquired company within the Ferring Pharmaceuticals group
- Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated DiarrheaCompletedNCT01925417Phase 2
Sponsor listed in the registry: Rebiotix Inc. · Rebiotix Inc. — acquired company within the Ferring Pharmaceuticals group